PUBLIC HEALTH, MASSACHUSETTS DEPARTMENT OF: $181M Department of Health and Human Services Grant
Summary
This $181M grant to the Massachusetts Department of Public Health funds the state's opioid response program, but does not directly benefit any publicly traded company. The award supports treatment and prevention services for opioid and stimulant use disorders.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The $181M grant is a state-level public health award with no direct public company beneficiary.
- 2.Investors should not expect stock price movements from this contract as it does not flow to a publicly traded entity.
- 3.The award reinforces ongoing federal support for opioid crisis response, but does not signal a shift in sector dynamics.
Market Implications
No direct market implications for publicly traded companies. The contract is a pass-through grant to a state agency, so it does not generate revenue for any corporate entity. Investors should monitor future awards from SAMHSA that may go to public companies in the addiction treatment or pharmaceutical sectors.
Full Analysis
The Substance Abuse and Mental Health Services Administration awarded a $181M project grant to the Massachusetts Department of Public Health for the state's Opioid Response (SOR) program. The grant covers a three-year period from 2024 to 2027 and aims to increase access to medications for opioid use disorder, expand prevention and recovery services, and target high-risk populations. Since the recipient is a state government entity, no publicly traded company receives direct revenue from this award. The contract is a routine renewal of federal funding for state-level public health initiatives, which typically does not create material impacts for public equities. While the healthcare sector broadly benefits from sustained federal investment in addiction treatment, the lack of a direct corporate beneficiary limits stock-specific implications. Related legislation in the database, such as the Drug Deal Disclosure Act and the Health Records Enhancement Act, are neutral and low-impact, with no direct link to this grant's funding mechanism.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
DEPARTMENT OF HUMAN SERVICES HAWAII: $2.2B Department of Health and Human Services Grant
KANSAS DEPARTMENT OF HEALTH & ENVIRONMENT: $4.6B Department of Health and Human Services Grant
NEW MEXICO HEALTH CARE AUTHORITY: $9.4B Department of Health and Human Services Grant
HEALTH SERVICES KENTUCKY CABINET FOR: $18.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.1B Department of Health and Human Services Federal Award
ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM: $19.6B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
HEALTH CARE SERVICES, CALIFORNIA DEPARTMENT OF: $6.2B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Contract Details
Recipient
PUBLIC HEALTH, MASSACHUSETTS DEPARTMENT OF
Award Amount
$181,172,233
Awarding Agency
Department of Health and Human Services
Sub-Agency
Substance Abuse and Mental Health Services Administration
Contract Type
PROJECT GRANT (B)
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →